Wuhan Hiteck Biological Pharma Co Ltd (300683) — Net Asset Momentum
Wuhan Hiteck Biological Pharma Co Ltd (300683) recorded a net asset momentum of -3.4% as of December 2024, with net assets of CN¥2.41 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See how many days can Wuhan Hiteck Biological Pharma Co Ltd fund operations to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Wuhan Hiteck Biological Pharma Co Ltd Net Asset Momentum (2013–2024)
This chart tracks Wuhan Hiteck Biological Pharma Co Ltd's year-over-year net asset growth across 12 annual reporting periods from 2013 to 2024. The most recent momentum reading is -3.4%, with net assets of CN¥2.41 Billion CNY as of December 2024. Read Wuhan Hiteck Biological Pharma Co Ltd (300683) total liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Wuhan Hiteck Biological Pharma Co Ltd (2013–2024)
The table below shows the complete annual net asset history for Wuhan Hiteck Biological Pharma Co Ltd from 2013 to 2024, covering 12 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Wuhan Hiteck Biological Pharma Co Ltd market cap and net worth.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥2.41 Billion | CN¥2.94 Billion | CN¥525.05 Million | ▼ -3.4% |
| 2023 | CN¥2.50 Billion | CN¥2.97 Billion | CN¥475.73 Million | ▲ +6.9% |
| 2022 | CN¥2.34 Billion | CN¥2.71 Billion | CN¥371.20 Million | ▼ -0.3% |
| 2021 | CN¥2.34 Billion | CN¥2.70 Billion | CN¥354.46 Million | ▲ +35.8% |
| 2020 | CN¥1.72 Billion | CN¥2.19 Billion | CN¥461.62 Million | ▼ -2.0% |
| 2019 | CN¥1.76 Billion | CN¥2.17 Billion | CN¥409.03 Million | ▲ +3.0% |
| 2018 | CN¥1.71 Billion | CN¥2.16 Billion | CN¥445.77 Million | ▲ +4.0% |
| 2017 | CN¥1.64 Billion | CN¥1.91 Billion | CN¥265.62 Million | ▲ +133.6% |
| 2016 | CN¥703.35 Million | CN¥1.04 Billion | CN¥335.87 Million | ▲ +17.9% |
| 2015 | CN¥596.76 Million | CN¥872.49 Million | CN¥275.74 Million | ▲ +11.2% |
| 2014 | CN¥536.59 Million | CN¥801.37 Million | CN¥264.78 Million | ▲ +110.7% |
| 2013 | CN¥254.64 Million | CN¥441.07 Million | CN¥186.42 Million | — |